The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Travis, Benjamin Ross
    Director born in October 1975
    Individual (5 offsprings)
    Officer
    2018-10-18 ~ dissolved
    OF - Director → CIF 0
  • 2
    Heidinger, Joyce Ann
    Director born in May 1965
    Individual (36 offsprings)
    Officer
    2023-08-01 ~ dissolved
    OF - Director → CIF 0
  • 3
    PROTEALYSIS LIMITED - 2009-01-29
    Salisbury House, Station Road, Cambridge, England
    Active Corporate (4 parents, 1 offspring)
    Equity (Company account)
    1,000 GBP2023-12-31
    Person with significant control
    2018-10-18 ~ dissolved
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
Ceased 9
  • 1
    Purcell, Neil, Dr
    Chemist born in May 1958
    Individual (1 offspring)
    Officer
    2005-06-01 ~ 2018-10-18
    OF - Director → CIF 0
    Purcell, Neil, Dr
    Individual (1 offspring)
    Officer
    2006-01-28 ~ 2014-09-03
    OF - Secretary → CIF 0
    Dr Neil Purcell
    Born in May 1958
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ 2018-10-18
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 2
    Raeside, Anthony Ian
    Individual
    Officer
    1996-08-07 ~ 1998-02-25
    OF - Secretary → CIF 0
  • 3
    Carney, James, Dr
    Biochemist born in January 1944
    Individual
    Officer
    1996-08-07 ~ 2010-06-25
    OF - Director → CIF 0
    Carney, James, Dr
    Individual
    Officer
    1998-05-11 ~ 2006-01-27
    OF - Secretary → CIF 0
  • 4
    Blackfriar Directors Limited
    Individual
    Officer
    1996-08-07 ~ 1996-08-07
    OF - Nominee Director → CIF 0
  • 5
    Blackfriar Secretaries Limited
    Individual
    Officer
    1996-08-07 ~ 1996-08-07
    OF - Nominee Secretary → CIF 0
  • 6
    Drury, Michael Thomas
    Director born in February 1964
    Individual
    Officer
    2018-10-18 ~ 2022-07-29
    OF - Director → CIF 0
  • 7
    Brownleader, Mike Daniel
    Director born in January 1967
    Individual (2 offsprings)
    Officer
    2019-01-01 ~ 2022-05-22
    OF - Director → CIF 0
  • 8
    Allan, James Mark
    Director born in December 1967
    Individual (2 offsprings)
    Officer
    2023-08-01 ~ 2024-02-15
    OF - Director → CIF 0
  • 9
    Childerstone, Michael Steven, Dr
    Biochemist born in July 1959
    Individual (1 offspring)
    Officer
    1998-02-04 ~ 2018-10-18
    OF - Director → CIF 0
    Dr Michael Steven Childerstone
    Born in July 1959
    Individual (1 offspring)
    Person with significant control
    2016-04-06 ~ 2018-10-18
    PE - Ownership of shares – More than 50% but less than 75%CIF 0
parent relation
Company in focus

KALON BIOLOGICAL LIMITED

Standard Industrial Classification
20590 - Manufacture Of Other Chemical Products N.e.c.
Brief company account
Average Number of Employees
02022-01-01 ~ 2022-12-31
42021-01-01 ~ 2021-12-31
Fixed Assets - Investments
4,920 GBP2022-12-31
4,920 GBP2021-12-31
Debtors
7,701 GBP2022-12-31
7,701 GBP2021-12-31
Net Current Assets/Liabilities
7,701 GBP2022-12-31
7,701 GBP2021-12-31
Total Assets Less Current Liabilities
12,621 GBP2022-12-31
12,621 GBP2021-12-31
Equity
Called up share capital
100 GBP2022-12-31
100 GBP2021-12-31
Retained earnings (accumulated losses)
12,521 GBP2022-12-31
12,521 GBP2021-12-31
Equity
12,621 GBP2022-12-31
12,621 GBP2021-12-31
Investments in Group Undertakings
Cost valuation
4,920 GBP2021-12-31
Investments in Group Undertakings
4,920 GBP2022-12-31
4,920 GBP2021-12-31
Amounts Owed by Group Undertakings
Current
7,701 GBP2022-12-31
7,701 GBP2021-12-31

Related profiles found in government register
  • KALON BIOLOGICAL LIMITED
    Info
    Registered number 03234855
    Unit 5a - Calibre Scientific House, R-evolution@the Advanced Manufacturing Park, Selden Way, Catcliffe, Rotherham S60 5XA
    Private Limited Company incorporated on 1996-08-07 and dissolved on 2024-12-31 (28 years 4 months). The company status is Dissolved.
    The last date of confirmation statement was made at 2024-08-07
    CIF 0
  • KALON BIOLOGICAL LIMITED
    S
    Registered number 03234855
    Unit G Perram Works, Merrow Lane, Guildford, Surrey, England, GU4 7BN
    Private Company Limited By Shares in England And Wales
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • Unit 5a - Calibre Scientific House, R-evolution@the Advanced Manufacturing Park, Selden Way, Catcliffe, Rotherham, United Kingdom
    Dissolved Corporate (3 parents)
    Equity (Company account)
    4,920 GBP2023-12-31
    Person with significant control
    2016-04-06 ~ dissolved
    CIF 1 - Ownership of shares – 75% or moreOE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.